Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Research design
1.2.1 Research approach
1.2.2 Data collection methods
1.3 Base estimates & calculations
1.3.1 Base year calculation
1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
1.5.1 Primary sources
1.5.2 Data mining sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Growing prevalence of chronic disease
3.2.1.2 Rising R&D activities in the pharmaceutical industry
3.2.1.3 Rising demand for generic drugs
3.2.1.4 Rising adoption of outsourcing services
3.2.2 Industry pitfalls & challenges
3.2.2.1 Stringent regulatory compliance
3.3 Growth potential analysis
3.4 Future market trends
3.5 Regulatory landscape
3.6 Porter’s analysis
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Company matrix analysis
4.4 Competitive analysis of major market players
4.5 Company positioning matrix
4.6 Strategic dashboard
Chapter 5 Market Estimates and Forecast, By Product, 2021 – 2032 ($ Mn)
5.1 Key trends
5.2 Chemical APIs
5.3 Biological APIs
5.4 High potent APIs
Chapter 6 Market Estimates and Forecast, By Indication, 2021 – 2032 ($ Mn)
6.1 Key trends
6.2 Oncology
6.3 Cardiovascular diseases
6.4 Diabetes
6.5 Hormonal disorders
6.6 Infectious diseases
6.7 Other indications
Chapter 7 Market Estimates and Forecast, By Drug, 2021 – 2032 ($ Mn)
7.1 Key trends
7.2 Branded
7.3 Generic
Chapter 8 Market Estimates and Forecast, By Workflow, 2021 – 2032 ($ Mn)
8.1 Key trends
8.2 Clinical
8.3 Commercial
Chapter 9 Market Estimates and Forecast, By Application 2021 – 2032 ($ Mn)
9.1 Key trends
9.2 Human application
9.3 Veterinary application
Chapter 10 Market Estimates and Forecast, By End-Use, 2021 – 2032 ($ Mn)
10.1 Key trends
10.2 Pharmaceutical & biotech companies
10.3 Academic and research institutes
Chapter 11 Market Estimates and Forecast, By Region, 2021– 2032 ($ Mn)
11.1 Key trends
11.2 North America
11.2.1 U.S.
11.2.2 Canada
11.3 Europe
11.3.1 Germany
11.3.2 UK
11.3.3 France
11.3.4 Spain
11.3.5 Italy
11.3.6 The Netherlands
11.3.7 Rest of Europe
11.4 Asia Pacific
11.4.1 Japan
11.4.2 China
11.4.3 India
11.4.4 Australia
11.4.5 South Korea
11.4.6 Rest of Asia Pacific
11.5 Latin America
11.5.1 Brazil
11.5.2 Mexico
11.5.3 Rest of Latin America
11.6 Middle East and Africa
11.6.1 South Africa
11.6.2 Saudi Arabia
11.6.3 UAE
11.6.4 Rest of Middle East and Africa
Chapter 12 Company Profiles
12.1 Ajinomoto Biopharma Services
12.2 Boehringer Ingelheim
12.3 Cambex Corporation
12.4 Catalent, Inc.
12.5 CordenPharma International
12.6 Kymanox Corporation
12.7 Lonza AG
12.8 Primal Pharma Solutions
12.9 Recipharm AB
12.10 Samsung Biologics
12.11 Siegfried Holding AG
12.12 Thermo Fisher Scientific Inc.
